SEC Tracker
Get the app

Iambic Therapeutics IAM

William H Rastetter reports ownership

William H Rastetter, new insider at Iambic Therapeutics, Inc.

Form
3
Filed
Importance
Routine
  1. William H. Rastetter filed Form 3 on Oct 14, 2026
  2. Owns 76,801 Series B Convertible Preferred Stock
  3. Owns 66,556 stock options
  4. Holds 8,341 convertible promissory notes

Written from the Form 3 on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Iambic Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2836) and public float not reported.

  1. Adaptimmune Therapeutics ADAP
  2. Adverum Biotechnologies ADVM
  3. AgomAb Therapeutics AGMB
  4. Alvotech ALVO
  5. Argenx ARGX